BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PBX1, P40424, 5087 AND Clinical Outcome
12 results:

  • 1. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical features and prognostic impact of TCF3-pbx1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and clinical outcome in Acute Lymphoblastic Leukemia.
    Chen D; Zheng J; Gerasimcik N; Lagerstedt K; Sjögren H; Abrahamsson J; Fogelstrand L; Mårtensson IL
    PLoS One; 2016; 11(9):e0162638. PubMed ID: 27611867
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
    ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
    Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
    Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-pbx1.
    Jeha S; Pei D; Raimondi SC; Onciu M; Campana D; Cheng C; Sandlund JT; Ribeiro RC; Rubnitz JE; Howard SC; Downing JR; Evans WE; Relling MV; Pui CH
    Leukemia; 2009 Aug; 23(8):1406-9. PubMed ID: 19282835
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation.
    Piccaluga PP; Malagola M; Rondoni M; Ottaviani E; Testoni N; Laterza C; Visani G; Pileri SA; Martinelli G; Baccarani M
    Leuk Lymphoma; 2006 Mar; 47(3):469-72. PubMed ID: 16396770
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia.
    Elia L; Mancini M; Moleti L; Meloni G; Buffolino S; Krampera M; De Rossi G; Foà R; Cimino G
    Haematologica; 2003 Mar; 88(3):275-9. PubMed ID: 12651265
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. E2A-pbx1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
    Hunger SP; Fall MZ; Camitta BM; Carroll AJ; Link MP; Lauer SJ; Mahoney DH; Pullen DJ; Shuster JJ; Steuber CP; Cleary ML
    Blood; 1998 Feb; 91(3):1021-8. PubMed ID: 9446665
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Persistence of E2A/pbx1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.
    Lanza C; Gottardi E; Gaidano G; Vivenza C; Parziale A; Perfetto F; Fornaci M; Barisone E; Madon E; Basso G; Saglio G
    Leuk Res; 1996 May; 20(5):441-3. PubMed ID: 8683984
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Reverse transcriptase/polymerase chain reaction follow-up and minimal residual disease detection in t(1;19)-positive acute lymphoblastic leukaemia.
    Privitera E; Rivolta A; Ronchetti D; Mosna G; Giudici G; Biondi A
    Br J Haematol; 1996 Mar; 92(3):653-8. PubMed ID: 8616031
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.